It occurred to me that in my position performing, directing and reviewing market research on a global scale that it would be worthwhile to highlight recent insights that have come to me regarding the global medical technology market. Some of these insights, of course, may only be meaningful to me (and those who have a [...]
Medtech financings year to date (through August 2010) now stand at $2.57 billion, about 17% ahead of financings by this date in 2009. August 2010 financing came in at a modest $267 million, following the year-high month of July which had financings of $518 million. If the remainder of 2010 follows a typical course, total [...]
Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]
With medical technology financing driven way over the top by the $151.5 million financing by Devicor Medical Products (acquirer of J&J's Ethicon Endo-Surgery breast-care business), the July 2010 total hit a year high-to-date $518.3 million. See individual financings below. Replication Medical, Inc., has raised $1.1 million in funding according to a regulatory filing (implantable hydrogel [...]
Medtech financings for the month of July are on track to likely pass $500 million, driven primarily by the $151 million funding by Devicor Medical Products, who recently acquired the breast-care business of J&J's Ethicon Endo-Surgery unit. Other significant financings contributing to the total include $60 million for TriVascular, $45 million for Theranos, $40 million [...]
Four medical technology financings over the past week totalling over $180 million have driven the month's current total to almost $250 million dollars. When most medtech financings have been in the $5-$10 million range, these four stick out as clear exceptions: TriVascular, Inc. — $60 million — technology for repair of abdominal aortic aneurysms Theranos Inc. [...]
(Please pardon the slow loading or awkward presentation of the data below while we test optional ways to embed Google Spreadsheets into our WordPress posts to allow active updates to the blog as spreadsheet data changes.) Below is the spreadsheet listing of medtech financings for July 2010. This blog post will reflect in the spreadsheet [...]
Medical technology financings for July 2010 are off to a modest start. As of July 7, total medtech financings stood at $97.3 million, driven by DFIne ($36.2MM), Uptake Medical ($17.5MM), and Neoprobe ($14MM). For a running list of July 2010 financings, see link. bookmark to
Historically, closure of surgical incisions has been achieved through an ever-evolving portfolio of suture, staple and tape products. In the early 1990s, physicians involved in sports medicine were the first non-military practitioners to adopt cyanoacrylate glues to achieve immediate closure of small cuts and lacerations, and an awareness of this opportunity developed in large multinational [...]
With the late month close by AqueSys of a $35 million funding round, total medtech financings from venture capital and other sources have reached a respectable $312 million for the month of June. These include the following significant fundings: OptiNose AS, $48.5 million — nasal drug delivery technology AqueSys, Inc., $35 million — glaucoma treatment [...]
Contact:
